Search research articles
Contact Us
Filters
Showing results (131-140 of 173) with videos related to
Page
of 18
Sort By:
JMIR Formative Research
|
March 15, 2024
A Closed-Loop Digital Health Tool to Improve Depression Care in Multiple Sclerosis: Iterative Design and Cross-Sectional Pilot Randomized Controlled Trial and its Impact on Depression Care
Kyra Henderson, Jennifer Reihm, Kanishka Koshal, et al.
The Lancet. Neurology
|
March 17, 2023
Family planning considerations in people with multiple sclerosis
Kristen M Krysko, Ruth Dobson, Raed Alroughani, et al.
Neurology. Clinical Practice
|
March 2, 2026
Expert Opinion on Age-Related Sex Hormone Changes and Hypogonadism in People With Multiple Sclerosis: A Delphi Consensus Program
Riley Bove, Manuela Simoni, Camil Castelo-Branco, et al.
Multiple Sclerosis and Related Disorders
|
March 25, 2022
Persistently reduced humoral and sustained cellular immune response from first to third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients
Hamza Mahmood Bajwa, Frederik Novak, Anna Christine Nilsson, et al.
JAMA Network Open
|
March 16, 2019
Association of Continuous Assessment of Step Count by Remote Monitoring With Disability Progression Among Adults With Multiple Sclerosis
Valerie J Block, Riley Bove, Chao Zhao, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
October 31, 2015
Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis
Riley Bove, Charles C White, Gavin Giovannoni, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
March 15, 2023
Inflammatory Activity After Diverse Fertility Treatments: A Multicenter Analysis in the Modern Multiple Sclerosis Treatment Era
Edith L Graham, Jennifer B Bakkensen, Annika Anderson, et al.
Multiple Sclerosis and Related Disorders
|
January 6, 2023
Longitudinal adaptive immune responses following sequential SARS-CoV-2 vaccinations in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulators
Joseph J Sabatino, Kristen Mittl, William Rowles, et al.
JAMA Neurology
|
August 13, 2019
Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years
Ester Cantó, Christian Barro, Chao Zhao, et al.
Neuroreport
|
August 8, 2014
An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2
Rohit Bakshi, Mohit Neema, Shahamat Tauhid, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 173) with videos related to
Sort By:
Page
of 18
JMIR Formative Research
|
March 15, 2024
A Closed-Loop Digital Health Tool to Improve Depression Care in Multiple Sclerosis: Iterative Design and Cross-Sectional Pilot Randomized Controlled Trial and its Impact on Depression Care
Kyra Henderson, Jennifer Reihm, Kanishka Koshal, et al.
The Lancet. Neurology
|
March 17, 2023
Family planning considerations in people with multiple sclerosis
Kristen M Krysko, Ruth Dobson, Raed Alroughani, et al.
Neurology. Clinical Practice
|
March 2, 2026
Expert Opinion on Age-Related Sex Hormone Changes and Hypogonadism in People With Multiple Sclerosis: A Delphi Consensus Program
Riley Bove, Manuela Simoni, Camil Castelo-Branco, et al.
Multiple Sclerosis and Related Disorders
|
March 25, 2022
Persistently reduced humoral and sustained cellular immune response from first to third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients
Hamza Mahmood Bajwa, Frederik Novak, Anna Christine Nilsson, et al.
JAMA Network Open
|
March 16, 2019
Association of Continuous Assessment of Step Count by Remote Monitoring With Disability Progression Among Adults With Multiple Sclerosis
Valerie J Block, Riley Bove, Chao Zhao, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
October 31, 2015
Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis
Riley Bove, Charles C White, Gavin Giovannoni, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
March 15, 2023
Inflammatory Activity After Diverse Fertility Treatments: A Multicenter Analysis in the Modern Multiple Sclerosis Treatment Era
Edith L Graham, Jennifer B Bakkensen, Annika Anderson, et al.
Multiple Sclerosis and Related Disorders
|
January 6, 2023
Longitudinal adaptive immune responses following sequential SARS-CoV-2 vaccinations in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulators
Joseph J Sabatino, Kristen Mittl, William Rowles, et al.
JAMA Neurology
|
August 13, 2019
Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years
Ester Cantó, Christian Barro, Chao Zhao, et al.
Neuroreport
|
August 8, 2014
An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2
Rohit Bakshi, Mohit Neema, Shahamat Tauhid, et al.
Page
of 18